Skip to main content
. 2024 Jul 20;3(4):100303. doi: 10.1016/j.jacig.2024.100303

Fig 2.

Fig 2

Use of INCs in previous years, with the starting point of users in 2019 to a maximum of 5 years. Results are described as absolute values. Each prevalence rate indicates a prescription in consecutive years: 2019 includes an INC prescription written in 2019; 2018-2019 includes a consecutive INC prescription in 2018 and 2019; 2017-2019 includes a consecutive INC prescription in 2017, 2018, and 2019; 2016-2019 includes a consecutive INC prescription in 2016, 2017, 2018, and 2019; and 2015-2019 includes a consecutive INC prescription in 2015, 2016, 2017, 2018, and 2019. First, the number of users who received an INC prescription in 2019 in the first place was determined in the data set. Next, on the basis of a unique identifier, the number of the users in 2019 who also had a prescription in 2018 was determined. Then, the number of those users who also had a prescription in 2017. This procedure was then repeated for 2016 and 2015. For example, in this figure the those using an INC in 2017-2019 are included in the group of those using an INC in 2018-2019.